Published in Curr Opin Gastroenterol on March 01, 2014
Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome. Dig Dis Sci (2015) 1.43
The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol (2015) 1.25
Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model. Dig Dis Sci (2014) 1.08
Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol (2014) 1.06
Serial Frozen Fecal Microbiota Transplantation in the Treatment of Chronic Intestinal Pseudo-obstruction: A Preliminary Study. J Neurogastroenterol Motil (2016) 0.95
Management of gastrointestinal involvement in scleroderma. Curr Treatm Opt Rheumatol (2015) 0.84
Role of Small Intestinal Bacterial Overgrowth in Functional Gastrointestinal Disorders. J Neurogastroenterol Motil (2016) 0.76
Probiotics, prebiotics & synbiotics in small intestinal bacterial overgrowth: opening up a new therapeutic horizon! Indian J Med Res (2014) 0.76
Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther (2017) 0.75
Enterococcus faecalis readily colonizes the entire gastrointestinal tract and forms biofilms in a germ-free mouse model. Virulence (2016) 0.75
New insights in IBS-like disorders: Pandora's box has been opened; a review. Gastroenterol Hepatol Bed Bench (2017) 0.75
Leadership in medicine: do we need a new approach? Am J Gastroenterol (2014) 0.75